The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

Moderna stock veered higher Monday after its flu shot proved to be as effective as older technology in a final-phase study.

Discover how mRNA vaccines could revolutionize medicine by targeting 9 major diseases. Learn about breakthrough treatments ...

Researchers use targeted lipid nanoparticles loaded with mRNA to reprogram T cells to fight autoimmune diseases ...

Moderna's messenger RNA flu vaccine candidate has shown has shown positive results in a late-stage trial. The biotechnology company said Monday its seasonal influenza vaccine candidate, mRNA-1010, ...

Brazil's Alexandre Padilha admitted Tuesday at the at the 15th BRICS Health Ministers' Meeting in Brasilia that his country ...

Two species of worms have retained remarkably similar patterns in the way they switch their genes on and off despite having ...